BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 15728899)

  • 1. c-di-GMP (3'-5'-cyclic diguanylic acid) inhibits Staphylococcus aureus cell-cell interactions and biofilm formation.
    Karaolis DK; Rashid MH; Chythanya R; Luo W; Hyodo M; Hayakawa Y
    Antimicrob Agents Chemother; 2005 Mar; 49(3):1029-38. PubMed ID: 15728899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3',5'-cyclic diguanylic acid reduces the virulence of biofilm-forming Staphylococcus aureus strains in a mouse model of mastitis infection.
    Brouillette E; Hyodo M; Hayakawa Y; Karaolis DK; Malouin F
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3109-13. PubMed ID: 16048911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of c-di-GMP (3'-5'-cyclic diguanylic acid) on the biofilm formation and adherence of Streptococcus mutans.
    Yan W; Qu T; Zhao H; Su L; Yu Q; Gao J; Wu B
    Microbiol Res; 2010 Feb; 165(2):87-96. PubMed ID: 19186044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3',5'-Cyclic diguanylic acid (c-di-GMP) inhibits basal and growth factor-stimulated human colon cancer cell proliferation.
    Karaolis DK; Cheng K; Lipsky M; Elnabawi A; Catalano J; Hyodo M; Hayakawa Y; Raufman JP
    Biochem Biophys Res Commun; 2005 Apr; 329(1):40-5. PubMed ID: 15721270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of cyclic bis(3'-5')diguanylic acid and its analogs on bacterial biofilm formation.
    Ishihara Y; Hyodo M; Hayakawa Y; Kamegaya T; Yamada K; Okamoto A; Hasegawa T; Ohta M
    FEMS Microbiol Lett; 2009 Dec; 301(2):193-200. PubMed ID: 20169626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring of diguanylate cyclase activity and of cyclic-di-GMP biosynthesis by whole-cell assays suitable for high-throughput screening of biofilm inhibitors.
    Antoniani D; Bocci P; Maciag A; Raffaelli N; Landini P
    Appl Microbiol Biotechnol; 2010 Jan; 85(4):1095-104. PubMed ID: 19707751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacterial c-di-GMP is an immunostimulatory molecule.
    Karaolis DK; Means TK; Yang D; Takahashi M; Yoshimura T; Muraille E; Philpott D; Schroeder JT; Hyodo M; Hayakawa Y; Talbot BG; Brouillette E; Malouin F
    J Immunol; 2007 Feb; 178(4):2171-81. PubMed ID: 17277122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. c-di-GMP as a vaccine adjuvant enhances protection against systemic methicillin-resistant Staphylococcus aureus (MRSA) infection.
    Hu DL; Narita K; Hyodo M; Hayakawa Y; Nakane A; Karaolis DK
    Vaccine; 2009 Jul; 27(35):4867-73. PubMed ID: 19406185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3',5'-Cyclic diguanylic acid: a small nucleotide that makes big impacts.
    Yan H; Chen W
    Chem Soc Rev; 2010 Aug; 39(8):2914-24. PubMed ID: 20577685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amine skeleton-based c-di-GMP derivatives as biofilm formation inhibitors.
    Ikeda K; Yanase Y; Hayashi K; Hara-Kudo Y; Tsuji G; Demizu Y
    Bioorg Med Chem Lett; 2021 Jan; 32():127713. PubMed ID: 33271284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The potential of 3',5'-cyclic diguanylic acid (c-di-GMP) as an effective vaccine adjuvant.
    Chen W; Kuolee R; Yan H
    Vaccine; 2010 Apr; 28(18):3080-5. PubMed ID: 20197136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclic di-GMP signalling controls virulence properties of Salmonella enterica serovar Typhimurium at the mucosal lining.
    Lamprokostopoulou A; Monteiro C; Rhen M; Römling U
    Environ Microbiol; 2010 Jan; 12(1):40-53. PubMed ID: 19691499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of Growth, Cell Shape, Cell Division, and Gene Expression by Second Messengers (p)ppGpp and Cyclic Di-GMP in Mycobacterium smegmatis.
    Gupta KR; Baloni P; Indi SS; Chatterji D
    J Bacteriol; 2016 May; 198(9):1414-22. PubMed ID: 26903417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methicillin resistance and the biofilm phenotype in Staphylococcus aureus.
    McCarthy H; Rudkin JK; Black NS; Gallagher L; O'Neill E; O'Gara JP
    Front Cell Infect Microbiol; 2015; 5():1. PubMed ID: 25674541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracellular protease in Actinomycetes culture supernatants inhibits and detaches Staphylococcus aureus biofilm formation.
    Park JH; Lee JH; Kim CJ; Lee JC; Cho MH; Lee J
    Biotechnol Lett; 2012 Apr; 34(4):655-61. PubMed ID: 22160331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nucleotide Messenger Signaling of Staphylococci in Responding to Nitric Oxide - Releasing Biomaterials.
    Ochetto A; Sun D; Siedlecki CA; Xu LC
    ACS Biomater Sci Eng; 2023 Jun; 9(6):3285-3296. PubMed ID: 37155716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biofilm infections, their resilience to therapy and innovative treatment strategies.
    Römling U; Balsalobre C
    J Intern Med; 2012 Dec; 272(6):541-61. PubMed ID: 23025745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. c-di-GMP-mediated regulation of virulence and biofilm formation.
    Cotter PA; Stibitz S
    Curr Opin Microbiol; 2007 Feb; 10(1):17-23. PubMed ID: 17208514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclic-di-GMP stimulates keratinocyte innate immune responses and attenuates methicillin-resistant Staphylococcus aureus colonization in a murine skin wound infection model.
    Gao S; Khan A; Chen X; Xiao G; van der Veen S; Chen Y; Lin X
    BMC Microbiol; 2022 Jul; 22(1):176. PubMed ID: 35804301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thiazole orange-induced c-di-GMP quadruplex formation facilitates a simple fluorescent detection of this ubiquitous biofilm regulating molecule.
    Nakayama S; Kelsey I; Wang J; Roelofs K; Stefane B; Luo Y; Lee VT; Sintim HO
    J Am Chem Soc; 2011 Apr; 133(13):4856-64. PubMed ID: 21384923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.